Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,723,868
-$4,425,834 QoQ
Shares Held
731,255
-30.4% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 90.71363614607763.ToString("F0")%
Shared 0.ToString("F0")%
None 9.286363853922367.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. TRVI ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in TRVI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,723,868 | 731,255 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,149,702 | 1,050,296 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $39,360,790 | 4,301,726 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $5,601,338 | 1,024,011 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,110,824 | 494,567 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $786,378 | 190,869 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $662,921 | 198,480 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $265,160 | 88,981 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $235,381 | 68,227 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $199,660 | 149,003 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $75,675 | 34,714 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $90,320 | 37,791 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $710 | 384 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $846 | 439 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $659,743 | 428,405 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $1,295 | 589 | Shares | Defined | 2022-10-27 | |
| 2021-03-31 | $2,710 | 1,000 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||